<DOC>
	<DOCNO>NCT00631722</DOCNO>
	<brief_summary>This study attempt observe efficacy ( response time ) safety second-generation antipsychotic agent-quetiapine versus first-generation antipsychotic agent-haloperidol , treat acute schizophrenia episode evaluate effect effectiveness acute schizophrenia episode long-term tolerability .</brief_summary>
	<brief_title>Multicenter , Open-Label , Randomised , Haloperidol-controlled Study Evaluate Seroquel Mono-Therapy Treatment Agitated Symptoms Patients With Acute Episode Schizophrenia</brief_title>
	<detailed_description>Both medication patient affect compliance patient treatment . The control schizophrenia syndrome effectively rapidly build confidence patient treatment . These early effect may influence long-term compliance prognosis patient . And antipsychotic medication neuroprotection effect significantly improve long-term prognosis patient , too.In past , always think `` delayed onset antipsychotic '' antipsychotic medication . Recently , large sample study indicate onset antipsychotic effect early first day administration ( 24 hour ) . This study carry order compare second-generation antipsychotic agent- quetiapine first-generation antipsychotic agent- haloperidol onset time treatment .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<criteria>1 . Written inform consent provide legal guardian and/or patient . 2 . Age 1860 year old ( inclusion ) , male female , inpatient outpatient . 3 . A diagnosis schizophrenia ICD10 criterion F20.0 , F20.1 , F20.2 F20.3 . 4 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment . 5 . Able understand comply requirement study . 6 . PANSS total score least 60 EC factor score least 15 screen randomisation . 1 . Pregnancy lactation . 2 . Diagnosis mental disorder include mood disorder , schizoform disorder , schizoaffective disorder , delusional disorder , transient psychotic disorder etc . 3 . Patients , opinion investigator , pose imminent risk suicide danger self others . 4 . Known intolerance lack response quetiapine fumarate haloperidol , judge investigator . 5 . Known lack response clozapine , judge investigator . 6 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir . 7 . Use follow cytochrome P450 inducer 14 day precede enrollment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoid . 8 . Within one dose interval long act antipsychoticsUse . 9 . Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define ICD10 criterion . 10 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse ICD10 criterion within 28 day prior enrolment . 11 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment . 12 . Unstable inadequately treat medical illness ( e.g . CHF congestive heart failure , angina pectoris , hypertension ) judge investigator . 13 . Involvement plan conduct study . 14 . Previous enrolment randomisation treatment present study . 15 . Participation another drug trial within 28 day prior enrolment study longer accordance local requirement . 16 . Use antipsychotic 2 day prior study treatment 17 . Use clozapine 28 day prior study treatment . 18 . Use ECT 1 month prior screen . 19 . Initiate quetiapine haloperidol treatment within 30 day prior screen . 20 . Use MAOI 14 day prior study treatment 21 . The patient 's complete blood count ( CBC ) white blood cell ( WBC ) differential show neurotrophil count â‰¤ 1.5 x 109/L screen 22 . A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrollment glycosylated hemoglobin ( HbA1c ) &gt; 8.5 % Admitted hospital treatment DM DM relate illness past 12 week Not physician care DM Physician responsible patient 's DM care indicate patient 's DM control Physician responsible patient 's DM care approve patient 's participation study Has dose oral hypoglycaemic drug ( ) and/or diet 4 week prior allocation treatment . For thiazolidinediones ( glitazones ) period le 8 Weeks Taking insulin whose daily dose one occasion past 4 week 10 % mean dose precede 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>PANSS</keyword>
	<keyword>Acute Episode Schizophrenia</keyword>
</DOC>